No significant changes were observed in MRC and SF-36 over time, though SF-36 showed a positive trend.
← all excerpts
AbobotulinumtoxinA: A New Therapy for Hip Osteoarthritis. A Prospective Randomized Double-Blind Multicenter Study.
1
—
—
No significant changes were observed in MRC and SF-36 over time, though SF-36 showed a positive trend.